Drug Search Results
More Filters [+]

Colforsin

Alternative Names: colforsin, forskolin
Latest Update: 2023-10-19
Latest Update Note: News Article

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Ecuador | India | Malaysia

Approved Indications: None

Known Adverse Events: None

Company: Guangdong Lion Pharmaceutical Research Institute Co., Ltd. /Dalian Fusheng Natural Pharmaceutical Development Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Colforsin

Countries in Clinic: Unknown Location

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Common Cold|Headache|Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20192482

P2

Not yet recruiting

Headache|Common Cold|Influenza, Human

None

Recent News Events